OPPORTUNITIES FOR CANCER RISK ASSESSMENT AND PROGNOSIS

Improving cancer risk assessment and prognosis: the role of Multianalyte Assays with Algorithmic Analyses provides insights on Multianalyte Assays with Algorithmic Analysis (MAAAs), which are tests that combine two or more biomarkers into an algorithm to generate a disease risk assessment or prognostic result. These tests potentially offer better performance than single biomarker.

ANALYZING CURRENT PRACTICES

MAAAs have been adopted for use in Eastern Countries such as China, but to this point, Western Countries, particularly European and North American countries, have not embraced these algorithms. We explore the use of these algorithms in areas where they have been incorporated into screening and testing protocols and discuss potential reasons why there has been less uptake for use in other places.